
Rikspas MF 80mg/250mg Tablet
Marketer
Biorika Healthcare
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Rikspas MF 80mg/250mg Tablet
Abdomialgia relief is provided by the combined-action tablet, Rixpam MF 80mg/250mg. This medication alleviates abdominal pain, distension, discomfort, and spasms by inducing gastrointestinal muscle relaxation and inhibiting pain-signaling neurotransmitters. Rixpam MF 80mg/250mg should be ingested with food, following your physician's prescribed dosage and regimen. Treatment duration and specific dosage are tailored to your individual response and medical condition. Complete the prescribed course; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all concurrent medications, as interactions may occur. Common, typically transient, side effects include diarrhea, nausea, emesis, abdominal pain, xerostomia, anorexia, thirst, and pyrosis. Report any concerning side effects immediately. Dizziness and somnolence are potential effects; avoid operating machinery or driving until their impact is ascertained. Alcohol consumption should be avoided due to potential dizziness exacerbation. Disclose pregnancy, pregnancy planning, or breastfeeding to your physician before commencing treatment. Kidney or liver dysfunction should also be reported to ensure appropriate dosage adjustments.
Uses of Rikspas MF 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Rikspas MF 80mg/250mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment schedule. Ingest the 80mg/250mg Rikspas MF tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.
Common Side effects of Rikspas MF 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Rikspas MF 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 80mg/250mg Rikspas MF Tablet whole; do not break, crush, or chew it. Administer this medicine with a meal.
How Rikspas MF 80mg/250mg Tablet works:
Each Rikspas MF 80mg/250mg tablet combines drotaverine and mefenamic acid to alleviate abdominal discomfort and cramping. Drotaverine, an antispasmodic agent, targets abdominal smooth muscle spasms, easing contractions. Mefenamic acid, a non-steroidal anti-inflammatory drug (NSAID), reduces pain and inflammation by inhibiting the production of specific inflammatory mediators.
SAFETY ADVICE
AlcoholUNSAFE
Combining Rikspas MF 80mg/250mg tablets with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Rikspas MF 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against the risks prior to prescribing this medication. Seek medical advice before using this drug.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Rikspas MF 80mg/250mg Tablet while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by Rikspas MF 80mg/250mg Tablets, a potential side effect due to the medication's vertigo-inducing properties.
KidneyCAUTION
Patients with kidney impairment should use Rikspas MF 80mg/250mg Tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Rikspas MF 80mg/250mg Tablets; consult a physician for guidance.
LiverCAUTION
Patients with liver impairment should exercise caution when using Rikspas MF 80mg/250mg tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Rikspas MF 80mg/250mg Tablet :
Should you forget a Rikspas MF 80mg/250mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.
Facts to Know About Rikspas MF 80mg/250mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Medication | Gastrointestinal system |
